Voyager Therapeutics Inc.

Voyager Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Voyager Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 2.6 M, a 59.94% decrease year-over-year.
• Voyager Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 27.6 M, a 64.73% decrease year-over-year.
• Voyager Therapeutics Inc. annual revenue for 2025 was 40.4 M, a 49.53% decrease from 2024.
• Voyager Therapeutics Inc. annual revenue for 2024 was 80.0 M, a 68.00% decrease from 2023.
• Voyager Therapeutics Inc. annual revenue for 2023 was 250.0 M, a 511.16% increase from 2022.
• Voyager Therapeutics Inc. annual revenue for 2022 was 40.9 M.